gender

Caregiving and influenza risk

Monday, December 11, 2017 - 10:36

Caregiving has traditionally been a female area, both domestically and in the workplace. Due to the nature of influenza, healthcare workers and those in close contact with young children are at a greater risk of exposure to influenza viruses, both seasonal outbreaks and pandemic strains (Zhang et al 2011). Studies have generally shown compliance rates from as low as 10% to 40-50% among healthcare workers, with no clear pattern to ascertain why this is (Tell Me 2012).

Target: 
Citizens, Healthcare Professionals
Topic: 
Gender, Human Rights, Stakeholders
Tags: 
gender, gender issues, influenza

Hard to reach groups in public health

Monday, December 11, 2017 - 10:25

There are a number of groups that are especially vulnerable in terms of susceptibility to influenza and barriers to accessing vaccinations. This may lead to larger problems in case of a pandemic; for example, in the H1N1 2009 outbreak in Australia, indigenous Australians, a hard to reach group, were overrepresented in rates of hospitalisation (Seale et al 2010). Hard to reach groups may have adverse health outcomes, and the complex interplay of gender and social and economic marginalisation makes this a particular issue for women (Davidson et al 2011).

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Gender, Human Rights, Stakeholders, Vaccination
Tags: 
gender, gender issue, inequities, Roma

Pregnancy and influenza

Monday, November 13, 2017 - 12:39

Women who are pregnant are more likely to have severe disease and hospitalisation with either seasonal or pandemic influenza, compared to the general population or compared to non-pregnant women of the same age group. During pandemics, the mortality rate for pregnant women is higher than non-pregnant women. However, this is not the case with seasonal influenza unless the strain is particularly severe (WHO 2010).

Target: 
Citizens, Healthcare Professionals
Topic: 
Epidemiology, Gender, Stakeholders, Vaccination
Tags: 
gender issues, gender, influenza, flu, Vaccine

Women and Asthma in the EU

European Institute of Women’s Health. October 2014.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, asthma, policy, Pregnancy

Women and Diabetes in the EU

European Institute of Women’s Health. January 2013.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, diabetes, cardivascular diseases, Pregnancy, policy

Women and Cardiovascular Disease in the EU

European Institute of Women’s Health. February 2013.

Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It also is a major cause of serious illness and disability, costly to healthcare systems and destroying women’s quality of life. In the EU, CVD remains the top cause of death for women in each of the twenty-seven EU countries. Only during the last decades has awareness been rising how CVD affects women differently from men, alerting women to their risk. 

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, cardivascular diseases, Pregnancy, policy

Gender integration in Horizon 2020

Tuesday, June 20, 2017 - 09:04

Gender is considered a main issue in Horizon 2020, the largest ever EU Research and Innovation programme, with €80 billion worth of funding available over seven years. The European Commission has identified seven priority areas of societal challenges, with the goal targeting investment in research in these fields. They are:

Target: 
Decision Makers, Government and Public Health
Topic: 
Gender, Human Rights, Mutual Learning, Policy, Prevention, Stakeholders
Tags: 
gender, gender issues, science and society, clinical trials, Horizon 2020, research

Sex & Gender: The Politics, Policy, and Practice of Medical Research

Keitt SK. Yale J Health Policy Law Ethics. 2003 Summer;3(2):253-78.

Topic: 
Gender
Tags: 
Sex, gender, ​research, clinical trials, policy, law

ICH - Gender Consideration In The Conduct Of Clinical Trials

EMEA - European Medicines Agency. January 2005.

Topic: 
Gender
Tags: 
gender, clinical trials, ICH guidelines

​Policy Brief #5: Gender Imbalances in Health Research

The ENGENDER Project. October 2011.

Taking Action to Improve the Evidence Base for Policies by Changing Gender Imbalances in the Content and Process of Health Research. 

What are the mechanisms behind gender imbalances in the contents and processes of health research?
Gender discrimination and bias not only affects differentials in health needs, health seeking behaviour, treatment, and health outcomes but also influences the content and the process of health research.

 

Topic: 
Gender
Tags: 
gender, research, equity, policy

Pages

Subscribe to gender

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence